| K-number | K221007 |
| Device name | cobas HCV |
| Applicant | Roche Molecular Systems, Inc. |
| Product code | MZP |
| Device class | Class II |
| Decision date | Nov 4, 2022 |
| Decision | Substantially Equivalent |
| Regulation | 866.3170 |
AI extraction for this record is queued and will appear within 24 hours. View full FDA record →
View the full FDA submission: accessdata.fda.gov